# Post-market Registry Study on the Safety and Efficacy of ZENFLEX Pro™ Peripheral Drug-eluting Stent System for Femoropopliteal Artery Lesions

> **NCT07122167** · NA · RECRUITING · sponsor: **MDCECRO LLC** · enrollment: 153 (estimated)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **DEVICE:** Peripheral Drug-eluting Stent System

## Key facts

- **NCT ID:** NCT07122167
- **Lead sponsor:** MDCECRO LLC
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-02
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-02-01
- **Target enrollment:** 153 (ESTIMATED)
- **Last updated:** 2025-09-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07122167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07122167, "Post-market Registry Study on the Safety and Efficacy of ZENFLEX Pro™ Peripheral Drug-eluting Stent System for Femoropopliteal Artery Lesions". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07122167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*